Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.

Morocco’s largest hospital group’s share price tanks after successful IPO

Africa-focused private equity firm Mediterrania Capital Partners has made a successful exit from Akdital, Morocco's largest for-profit hospital group, with the biggest IPO on the Casablanca Stock Exchange since 2008. But despite being heavily over-subscribed, the share price has since fallen by 9%.

Orange and AXA buy pan-African digital health player

Telecoms giant Orange and insurer AXA will become majority shareholders of the appointment booking and telehealth platform DabaDoc, which operates mostly in Morocco, Tunisia and Algeria. It has intentions to expand across Sub-Saharan Africa.

Akdital plans pre-IPO expansion

Morocco's largest hospital group Akdital Holding is expanding nationwide ahead of its plans to file for IPO. The group is going public to finance its international expansion.

Payor reforms loom in GCC as COVID/expat exodus bites

Payors are maturing and providers are suffering from the double whammy of COVID and a declining expat population, said panellists at HBI's State of the Regions webinar on Middle East & North Africa (MENA). Other topics including hedging risk, public sector reform and how global trends are manifesting in the region.

Find Us